Neumora Therapeutics, Inc.
Clinical-stage biopharma developing precision medicines for brain diseases.
NMRA | US
Overview
Corporate Details
- ISIN(s):
- US6409791000
- LEI:
- Country:
- United States of America
- Address:
- 260 ARSENAL PLACE, SUITE 1, 2472 WATERTOWN
- Website:
- https://neumoratx.com/
- Sector:
- Manufacturing
Description
Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to redefining neuroscience drug development. The company focuses on creating precision medicines for brain diseases, including neuropsychiatric and neurodegenerative disorders. Neumora utilizes its proprietary 'Precision Toolbox,' an integrated data science platform, to identify patient subtypes and develop targeted therapies with novel mechanisms of action. This approach aims to address the significant unmet medical needs in brain health by applying the principles of precision medicine. The company's pipeline includes navacaprant, a clinical-stage candidate for the treatment of Major Depressive Disorder (MDD).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Neumora Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Neumora Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Neumora Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
